Hyperion Therapeutics to Present at the 2014 Wedbush Life Sciences Conference
August 07, 2014 09:15 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the company is scheduled to present at the Wedbush 2014 Life Sciences Conference on...
Hyperion Therapeutics to Report Second Quarter 2014 Financial Results After Market on August, 7, 2014
August 04, 2014 09:15 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Aug. 4, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that it will report second quarter 2014 financial results after market close on Thursday,...
Hyperion Therapeutics Announces EMA Acceptance for Review of Marketing Authorization Application for RAVICTI(R)
June 25, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., June 25, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the European Medicines Agency (EMA) has completed technical and content validation...
Hyperion Therapeutics to Present at the JMP Healthcare Conference
June 18, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., June 18, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) today announced that the company is scheduled to present at the JMP Healthcare Conference on Tuesday, June 24,...
Hyperion Therapeutics to Present at 2014 Wells Fargo Healthcare Conference
June 12, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., June 12, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) today announced that the company is scheduled to present at the 2014 Wells Fargo Healthcare Conference on...
Hyperion Therapeutics Completes Acquisition of Andromeda Biotech, Ltd.
June 12, 2014 08:46 ET
|
Hyperion Therapeutics, Inc.
- Hyperion's Orphan Drug Pipeline Now Includes DiaPep277®, a First-in-Class Immunotherapy for New Onset Type 1 Diabetes, With Phase 3 Data Expected in the First Quarter of 2015...
Hyperion Therapeutics Announces Health Canada Accepts RAVICTI(R) New Drug Submission With Priority Review
June 03, 2014 08:00 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., June 3, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the validation period is complete for its New Drug Submission (NDS) to Health Canada...
Hyperion Therapeutics to Present at Jefferies 2014 Global Healthcare Conference
May 28, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., May 28, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) today announced that the company is scheduled to present at the Jefferies Global Healthcare Conference on...
Hyperion Therapeutics to Present at Bank of America Merrill Lynch 2014 Health Care Conference
May 07, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., May 7, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) today announced that the company is scheduled to present at the Bank of America Merrill Lynch 2014 Health Care...
Hyperion Therapeutics Announces First Quarter 2014 Financial Results
May 06, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
- Company signs definitive agreement to expand its pipeline -
- Company to Host Conference Call Today at 4:30 p.m. ET (1:30 p.m. PT) -
BRISBANE, Calif., May 6, 2014 (GLOBE NEWSWIRE) --...